These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2567037)

  • 1. The new generation of serotonergic anxiolytics: possible clinical roles.
    Eison MS
    Psychopathology; 1989; 22 Suppl 1():13-20. PubMed ID: 2567037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V; Martínez Roig M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(4):155-67. PubMed ID: 1356293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models for anxiety and response to serotonergic drugs.
    Broekkamp CL; Berendsen HH; Jenck F; Van Delft AM
    Psychopathology; 1989; 22 Suppl 1():2-12. PubMed ID: 2567038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic anxiolytics and treatment of depression.
    Robinson DS; Alms DR; Shrotriya RC; Messina M; Wickramaratne P
    Psychopathology; 1989; 22 Suppl 1():27-36. PubMed ID: 2657837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin: a common neurobiologic substrate in anxiety and depression.
    Eison MS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and alcohol: interrelationships.
    Tollefson GD
    Psychopathology; 1989; 22 Suppl 1():37-48. PubMed ID: 2567040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 5-HT1A receptor: a new effective principle in psychopharmacologic therapy?].
    Davids E; Lesch KP
    Fortschr Neurol Psychiatr; 1996 Nov; 64(11):460-72. PubMed ID: 9064274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 13. Approaches to developing new anxiolytics and antidepressants.
    Dubovsky SL
    J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiologic basis of anxiety and its treatment.
    Salzman C; Miyawaki EK; le Bars P; Kerrihard TN
    Harv Rev Psychiatry; 1993; 1(4):197-206. PubMed ID: 9384849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).
    Tollefson GD; Montague-Clouse J; Tollefson SL
    J Clin Psychopharmacol; 1992 Feb; 12(1):19-26. PubMed ID: 1552035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of anxiolytics in children.
    Siméon JG
    Encephale; 1993; 19(2):71-4. PubMed ID: 7903927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.